185 related articles for article (PubMed ID: 25606382)
1. The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.
Hu S; Zhao L; Yang J; Hu M
Meta Gene; 2013 Dec; 1():126-37. PubMed ID: 25606382
[TBL] [Abstract][Full Text] [Related]
2. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.
Hu S; Zhao L; Yang J; Hu M
Tumour Biol; 2014 Apr; 35(4):3647-56. PubMed ID: 24326769
[TBL] [Abstract][Full Text] [Related]
3. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
Lv L; Wang P; Zhou X; Sun B
Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
[TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
[TBL] [Abstract][Full Text] [Related]
5. p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis.
Jia S; Tang W; Luo Y
Hepatol Int; 2013 Jun; 7(2):669-75. PubMed ID: 26201800
[TBL] [Abstract][Full Text] [Related]
6. Association of p53 codon 72 polymorphism with susceptibility to hepatocellular carcinoma in a Chinese population from northeast Sichuan.
Cai J; Cai Y; Ma Q; Chang F; Xu L; Zhang G; Guo X
Biomed Rep; 2017 Feb; 6(2):217-222. PubMed ID: 28357076
[TBL] [Abstract][Full Text] [Related]
7. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
[TBL] [Abstract][Full Text] [Related]
8. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
[TBL] [Abstract][Full Text] [Related]
9. Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis.
Lu Y; Liu Y; Zeng J; He Y; Peng Q; Deng Y; Wang J; Xie L; Li T; Qin X; Li S
Tumour Biol; 2014 May; 35(5):3997-4005. PubMed ID: 24488627
[TBL] [Abstract][Full Text] [Related]
10. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
[TBL] [Abstract][Full Text] [Related]
11. p53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies.
Chen X; Liu F; Li B; Wei YG; Yan LN; Wen TF
World J Gastroenterol; 2011 Mar; 17(9):1211-8. PubMed ID: 21448428
[TBL] [Abstract][Full Text] [Related]
12. No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.
Jiang N; Pan J; Wang L; Duan YZ
Tumour Biol; 2013 Feb; 34(1):587-96. PubMed ID: 23192640
[TBL] [Abstract][Full Text] [Related]
13. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
[TBL] [Abstract][Full Text] [Related]
14. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
15. Association between p53 polymorphism at codon 72 and recurrent spontaneous abortion.
Zhang Y; Wu YY; Qiao FY; Zeng WJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):402-405. PubMed ID: 27376811
[TBL] [Abstract][Full Text] [Related]
16. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yoon YJ; Chang HY; Ahn SH; Kim JK; Park YK; Kang DR; Park JY; Myoung SM; Kim DY; Chon CY; Han KH
Carcinogenesis; 2008 Jun; 29(6):1192-6. PubMed ID: 18390844
[TBL] [Abstract][Full Text] [Related]
17. The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population.
Ezzikouri S; El Feydi AE; Chafik A; Benazzouz M; El Kihal L; Afifi R; Hassar M; Pineau P; Benjelloun S
Hepatol Res; 2007 Sep; 37(9):748-54. PubMed ID: 17573955
[TBL] [Abstract][Full Text] [Related]
18. p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations.
Lao X; Chen Z; Qin A
Arch Gynecol Obstet; 2016 May; 293(5):1023-31. PubMed ID: 26493553
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis.
Alqumber MA; Akhter N; Haque S; Panda AK; Mandal RK
PLoS One; 2014; 9(4):e94874. PubMed ID: 24747975
[TBL] [Abstract][Full Text] [Related]
20. [Association of p53 codon 72 polymorphism with genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Zhu GS; Liu SF; Xian ZH; Wu WQ; Zhang XZ; Wang YH; Wu MC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):632-5. PubMed ID: 16331559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
